Cofounder IPO Product Development Seed Capital 
Steve Blank
MAY 9, 2017
When the product and channel are bits, adoption by 10’s and 100’s of millions and even billions of users can happen in years versus decades. For life sciences it was the Genentech IPO in 1980 that proved to investors that life science startups could make them a ton of money. Today startups build products differently.
Startup Lessons Learned
AUGUST 26, 2009
Provide early seed capital, and be the ones to make those introductions. And do your customer development. ► August (2) SXSW Case Study: SlideShare goes freemium ► July (4) Case Study: kaChing, Anatomy of a Pivot Some IPO speculation Founder personalities and the “first-class man&# th.
Expert insights. Personalized for you.
230 
Let's personalize your content